4.7 Article

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Allergy

Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome

Karoline Krause et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Letter Allergy

Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome

Heleen D. de Koning et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Review Rheumatology

Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature

J. T. Gran et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)

Article Dermatology

Schnitzler syndrome: response to anakinra in two cases and a review of the literature

Christian Schuster et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)

Article Immunology

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes

Helen J. Lachmann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Medicine, General & Internal

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Letter Allergy

IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission

John G. Ryan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)

Article Rheumatology

Beneficial response to anakinra and thalidomide in Schnitzler's syndrome

HD de Koning et al.

ANNALS OF THE RHEUMATIC DISEASES (2006)

Article Medicine, General & Internal

The RAND-36 measure of health-related quality of life

RD Hays et al.

ANNALS OF MEDICINE (2001)

Review Medicine, General & Internal

The Schnitzler syndrome - Four new cases and review of the literature

D Lipsker et al.

MEDICINE (2001)